UnitedHealth stock draws record buying as investors bet on Medicare growth

UnitedHealth Group is experiencing a surge in investor demand after a bullish thesis circulated on the Value Investing subreddit outlined multiple catalysts that could boost the health-insurance giant’s long-term valuation.

Trading activity signals rising institutional interest

The thesis, posted by the user MarketingReasonable4, highlights an unprecedented buying volume of approximately 394 million shares over the past month. UnitedHealth’s float stands at roughly 900 million shares, and 86.5 percent of that supply is now considered locked up. Should any institution surpass the 5 percent ownership threshold, Securities and Exchange Commission rules would require a Schedule 13G or 13D filing by mid-October. Market observers cited Berkshire Hathaway and Dodge & Cox as examples of firms with the scale to cross that line, though no such filing has yet been recorded.

UnitedHealth shares closed at $309.87 on 29 August. Based on data from Yahoo Finance, the stock traded at a trailing price-to-earnings ratio of 13.41 and a forward ratio of 18.80. Despite sideways price action following Justice Department news that offered little new information, the post argues that aggressive accumulation at current levels could position large investors for substantial upside.

Demographics and Medicare Advantage underpin revenue forecasts

According to the thesis, Americans aged 60 and older control about $84 trillion, or 70 percent of U.S. household wealth. This demographic trend supports continued growth in Medicare Advantage, where UnitedHealth commands a 29 percent market share. Enrollment in the program is projected to surpass 35 million by 2027, a figure broadly in line with estimates from the Centers for Medicare & Medicaid Services.

The author projects UnitedHealth’s revenue could reach $520 billion by the end of 2027 and exceed $600 billion in subsequent years. A margin expansion of just 0.5 percentage point could generate more than $3 billion in additional free cash flow, the post claims. Incorporating anticipated savings from artificial-intelligence applications across claims processing, diagnostics, and the Optum Health unit, MarketingReasonable4 suggests free cash flow might rise to $2,830 billion, implying a potential market valuation above $1 trillion at 17 times free cash flow.

AI efficiencies and policy backdrop cited as additional tailwinds

The thesis contends that AI-driven cost reductions will improve operating leverage, while the eventual normalization of Medicare pricing could further strengthen margins. Potential reversals of last year’s so-called “One Big Beautiful Bill” reimbursement cuts were noted as another positive policy catalyst. With roughly $7 trillion currently sitting in money-market funds, the post argues that ample liquidity exists to support renewed equity inflows.

Institutions already hold a significant portion of UnitedHealth’s float, and limited shares in public hands could amplify price moves if fresh demand emerges. The company’s history of steady free-cash-flow generation and consistent dividends is cited as a buffer against downside risks.

Context from earlier analyses

A separate bullish thesis published in May 2025 by Reddit user FluentInQuality emphasized UnitedHealth’s scale, vertical integration via its Optum segment, and pricing power tied to demographic trends. Since that analysis, the stock has gained roughly 5 percent. The new post echoes those themes but places greater emphasis on recent trading patterns and possible near-term regulatory filings.

While the Reddit commentary does not guarantee future performance, it offers one explanation for the elevated trading volumes observed in recent weeks. Market participants will be watching regulatory disclosures and Medicare enrollment figures for additional confirmation of the narrative.

For ongoing coverage of major health-care and financial developments, visit our Finance News Update section.

Image credit: original source